Veeva Systems can be found at many stages in the fight to quell the coronavirus epidemic, according to founder and CEO Peter Gassner.
In a world limited by social distancing and travel limitations, the cloud-computing company is assisting life sciences industry players in the research and development of new testing devices, treatments and vaccinations for COVID-19, the disease caused by the fast-spreading virus.
“We’re enabling them to [work] virtually” on the research and commercial fronts, Gassner told CNBC’s Jim Cramer in a “Mad Money” interview Thursday. “It’s a really exciting and busy time for Veeva and our industry.”
One of the products involved in the process is Veeva Engage, a customer relationship management platform tailored to life sciences companies. The system offers online video conferencing and content sharing applications. Health-care professionals are using the program to connect with doctors remotely to deliver care to patients, Gassner explained.